These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 15485290

  • 1. A comparative study between 12 and 24-dose therapeutic regimens for multibacillary leprosy patients.
    Sales AM, Sabroza PC, da Costa Nery JA, Duppre NC, Sarno EN.
    Int J Lepr Other Mycobact Dis; 2004 Sep; 72(3):320-3. PubMed ID: 15485290
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of a new fixed duration (12 weeks) multi-drug regimen of bactericidal drugs in multibacillary leprosy.
    Tejasvi T, Khaitan BK, Khanna N, Pandhi RK, Singh MK.
    Indian J Lepr; 2006 Sep; 78(4):329-37. PubMed ID: 17402345
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A study on the effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand; a prospective study, 1984-1996.
    Dasananjali K, Schreuder PA, Pirayavaraporn C.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):28-36. PubMed ID: 9207751
    [Abstract] [Full Text] [Related]

  • 5. [Multi-drug therapy trials for leprosy in Senegal: first observations relative to liver tolerance of multibacillary patients. Therapeutic consequences].
    Millan J, Roux G, Loko S, Naudin JC, Boucher P, Bodian M, Camara M, Moreira-Diop T, Grosset J.
    Acta Leprol; 1986 Mar; 4(4):427-44. PubMed ID: 3296613
    [Abstract] [Full Text] [Related]

  • 6. Combined 12-month WHO/MDT MB regimen and Mycobacterium w. vaccine in multibacillary leprosy: a follow-up of 136 patients.
    Kaur I, Dogra S, Kumar B, Radotra BD.
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):174-81. PubMed ID: 12483965
    [Abstract] [Full Text] [Related]

  • 7. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
    Shaw IN, Christian M, Jesudasan K, Kurian N, Rao GS.
    Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Comparative study of uniform-MDT and WHO MDT in Pauci and Multi bacillary leprosy patients over 24 months of observation.
    Rao PN, Suneetha S, Pratap DV.
    Lepr Rev; 2009 Jun; 80(2):143-55. PubMed ID: 19743618
    [Abstract] [Full Text] [Related]

  • 10. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
    Narang T, Kaur I, Kumar B, Radotra BD, Dogra S.
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Response to treatment by multidrug regimens in the THELEP controlled clinical drug trials. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1996 Dec; 67(4):260-79. PubMed ID: 9033197
    [Abstract] [Full Text] [Related]

  • 13. Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
    Villahermosa LG, Fajardo TT, Abalos RM, Cellona RV, Balagon MV, Dela Cruz EC, Tan EV, Walsh GP, Walsh DS.
    Am J Trop Med Hyg; 2004 Feb; 70(2):197-200. PubMed ID: 14993633
    [Abstract] [Full Text] [Related]

  • 14. Fixed-duration multidrug therapy in multibacillary leprosy.
    Li HY, Hu LF, Wu PW, Luo JS, Liu XM.
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):230-7. PubMed ID: 9251596
    [Abstract] [Full Text] [Related]

  • 15. Long-term efficacy of 2 year WHO multiple drug therapy (MDT) in multibacillary (MB) leprosy patients.
    Cellona RV, Balagon MF, dela Cruz EC, Burgos JA, Abalos RM, Walsh GP, Topolski R, Gelber RH, Walsh DS.
    Int J Lepr Other Mycobact Dis; 2003 Dec; 71(4):308-19. PubMed ID: 14763888
    [Abstract] [Full Text] [Related]

  • 16. Relapses in multibacillary leprosy patients after multidrug therapy.
    Poojabylaiah M, Marne RB, Varikkodan R, Bala N, Dandakeri S, Martis J.
    Lepr Rev; 2008 Sep; 79(3):320-4. PubMed ID: 19009982
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
    Sampoonachot P, Bundit C, Kuhacharoen N, Peerapakorn S, Kampirapap K, Poomlek A, Bampenyu S, Tiasiri S, Rungruang S, Surasondhi S, Supanwanit S, Wiriyawipart S.
    J Med Assoc Thai; 1996 Apr; 79(4):210-7. PubMed ID: 8708505
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gender differences in epidemiological factors associated with treatment completion status of leprosy patients in the most hyperendemic district of Nepal.
    Kumar RB, Singhasivanon P, Sherchand JB, Mahaisavariya P, Kaewkungwal J, Peerapakorn S, Mahotarn K.
    Southeast Asian J Trop Med Public Health; 2004 Jun; 35(2):334-9. PubMed ID: 15691132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.